Cold autoimmune hemolytic anemia
ICD-10 D59.12 is a billable code used to indicate a diagnosis of cold autoimmune hemolytic anemia.
Cold autoimmune hemolytic anemia (CAHA) is a type of hemolytic anemia characterized by the premature destruction of red blood cells due to the presence of autoantibodies that react at lower temperatures. This condition often occurs in association with certain infections, lymphoproliferative disorders, or can be idiopathic. Patients may present with symptoms such as fatigue, pallor, jaundice, and splenomegaly. The hemolysis is typically triggered by exposure to cold temperatures, leading to agglutination of red blood cells and subsequent hemolysis upon rewarming. Laboratory findings often include a positive direct Coombs test, elevated lactate dehydrogenase (LDH), decreased haptoglobin, and reticulocytosis. Management may involve avoiding cold exposure, corticosteroids, and in severe cases, splenectomy or immunosuppressive therapy. Understanding the underlying causes and associated conditions is crucial for effective treatment and management.
Detailed lab results, patient history, and treatment plans.
Diagnosis and management of hemolytic anemias, monitoring of treatment response.
Ensure clear documentation of autoimmune tests and any associated conditions.
Comprehensive autoimmune panel results and patient symptomatology.
Management of autoimmune disorders that may lead to hemolytic anemia.
Document any overlap with systemic autoimmune diseases.
Used to assess anemia severity and reticulocyte response.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure all lab results are clearly linked to the diagnosis.
Common symptoms include fatigue, pallor, jaundice, and splenomegaly, often exacerbated by exposure to cold temperatures.
Diagnosis is typically confirmed through a positive direct Coombs test, along with laboratory findings such as elevated LDH and decreased haptoglobin.
